Cancer Research and Treatment
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q2 | 67.9% | 1.462 | Q1 | 91.6% |
| 2024 | 3.8 | Q2 | 69.3% | 1.434 | Q1 | 91.6% |
| 2023 | 4.1 | Q2 | 68.7% | 1.254 | Q1 | 90.0% |
| 2022 | 4.6 | Q2 | 66.8% | 1.341 | Q1 | 91.6% |
| 2021 | 5.0 | Q2 | 67.6% | 1.359 | Q1 | 91.8% |
| 2020 | — | — | 1.668 | Q1 | 93.7% | |
| 2019 | — | — | 1.348 | Q1 | 91.1% | |
| 2018 | — | — | 1.466 | Q1 | 91.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2005-9256
ISSN
1598-2998
country
KRcoverage
2001, 2009, 2011-2026